Search Results - "Watkins, Robert W."

Refine Results
  1. 1

    Data-Driven Dose-Volume Histogram Prediction by Polizzi, Mitchell, Watkins, Robert W., Watkins, William T.

    Published in Advances in radiation oncology (01-03-2022)
    “…To evaluate dose-volume histogram (DVH) prediction from prior radiation therapy data. An Oncospace radiation therapy database was constructed including images,…”
    Get full text
    Journal Article
  2. 2

    Developing steady and dynamic ORP models for mercury emissions control in power plants using WFGD operating data by Lv, You, Romero, Carlos E., Charles, Joshua, Pauvlinch, Kayla A., Watkins, Robert W.

    Published in Fuel (Guildford) (01-01-2019)
    “…•Steady and dynamic ORP models are developed using LSSVM and WFGD operating data.•Input parameters are analyzed to develop the steady ORP model.•Time delays of…”
    Get full text
    Journal Article
  3. 3

    Antiplatelet and Antiproliferative Effects of SCH 51866, a Novel Type 1 and Type 5 Phosphodiesterase Inhibitor by Vemulapalli, Subbarao, Watkins, Robert W, Chintala, Madhu, Davis, Harry, Ahn, Ho-Sam, Fawzi, Ahmad, Tulshian, Deen, Chiu, Peter, Chatterjee, Meeta, Lin, Chin-Chung, Sybertz, Edmund J

    Published in Journal of cardiovascular pharmacology (01-12-1996)
    “…SUMMARYSCH 51866 is a potent and selective PDE1 and PDE5 inhibitor. The antiplatelet, antiproliferative, and hemodynamic effects of SCH 51866 were compared…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Disparate effects of thrombin receptor activating peptide on platelets and peripheral vasculature in rats by Chintala, Madhu S, Chiu, Peter J.S, Bernadino, Vernon, Tetzloff, Glen G, Tedesco, Richard, Sabin, Crawford, Watkins, Robert W, Sybertz, Edmund J

    Published in European journal of pharmacology (22-05-1998)
    “…The hemodynamic and platelet effects of the thrombin receptor activating peptide SFLLRN (TRAP) were evaluated in rats. TRAP failed to aggregate rat platelets…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Neutral metalloendopeptidase inhibitors as ANF potentiators: sites and mechanisms of action by Sybertz, Jr, E J, Chiu, P J, Watkins, R W, Vemulapalli, S

    “…Inhibition of the enzyme neutral metalloendopeptidase potentiates responses to atrial natriuretic factor and elicits reductions of blood pressure in…”
    Get more information
    Journal Article
  9. 9
  10. 10
  11. 11

    Disparate effects of phosphoramidon on blood pressure in SHR and DOCA-salt hypertensive rats by Vemulapalli, S, Watkins, R W, Brown, A, Cook, J, Bernardino, V, Chiu, P J

    Published in Life sciences (1973) (1993)
    “…Phosphoramidon inhibits both endothelin converting enzyme (ECE) and neutral metalloendopeptidase (NEP). The contribution of ECE and NEP inhibition to the…”
    Get more information
    Journal Article
  12. 12
  13. 13

    Effects of the antihypertensive dilevalol on aortic compliance in anesthetized dogs by Watkins, R W, Sybertz, E J, Antonellis, A, Pula, K, Rivelli, M

    Published in Journal of cardiovascular pharmacology (01-07-1988)
    “…The present study examined the actions of dilevalol, an antihypertensive beta-adrenoceptor blocker with arterial vasodilator actions, on aortic compliance (AC)…”
    Get more information
    Journal Article
  14. 14

    Hemodynamic actions of a synthetic atrial natriuretic factor by Baum, T, Sybertz, E J, Watkins, R W, Nelson, S, Coleman, W, Pula, K K, Prioli, N, Rivelli, M, Grossman, A

    Published in Journal of cardiovascular pharmacology (01-09-1986)
    “…The recently discovered atrial natriuretic factor (ANF), as well as synthetic ANF, has been demonstrated to produce diuresis and vasodilation. However, the…”
    Get more information
    Journal Article
  15. 15

    Pharmacologic, metabolic, and toxicologic profile of spirapril (SCH 33844), a new angiotensin converting inhibitor by Sybertz, E J, Watkins, R W, Ahn, H S, Baum, T, La Rocca, P, Patrick, J, Leitz, F

    “…Spirapril (SCH 33844; 7-N-[1(S)-ethoxycarbonyl-3-phenylpropyl]-(S)-alanyl-1,4-dithia- 7-azaspiro[4,4]-nonane-8(S)-carboxylic acid) is a new…”
    Get more information
    Journal Article
  16. 16
  17. 17

    Effects of the antihypertensive dilevalol on large artery compliance in anesthetized dogs by Watkins, R W, Sybertz, E J, Antonellis, A, Pula, K, Rivelli, M

    “…The present study examined the actions of dilevalol, an antihypertensive beta-adrenoceptor blocker with arterial vasodilator actions, upon aortic compliance…”
    Get more information
    Journal Article
  18. 18

    Antihypertensive activity of SCH 31846, a non-sulfhydryl angiotensin-converting enzyme inhibitor by Baum, T, Sybertz, E J, Watkins, R W, Ahn, H S, Nelson, S, Eynon, E, Vander Vliet, G, Pula, K K, Sabin, C, Desiderio, D M, Becker, F T, Vemulapalli, S

    Published in Journal of cardiovascular pharmacology (01-07-1983)
    “…The antihypertensive, hemodynamic, and autonomic actions of SCH 31846, a new, potent and long-acting non-sulfhydryl angiotensin-converting enzyme (ACE)…”
    Get more information
    Journal Article
  19. 19
  20. 20

    Inhibition of endothelial derived relaxing factor (EDRF) aggravates ischemic acute renal failure in anesthetized rats by CHINTALA, M. S, CHIU, P. J. S, SUBBARAO VEMULAPALLI, WATKINS, R. W, SYBERTZ, E. J

    “…The relative importance of endothelial derived relaxing factor (EDRF)/nitric oxide (NO) in maintaining kidney function in normal condition and in acute renal…”
    Get full text
    Journal Article